Published date: 2 October 2018

Last edited date: 2 October 2018

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 13 July 2018

Contract summary

Industry

  • Administrative healthcare services - 75122000

Location of contract

Any region

Value of contract

£0 to £100,000

Procurement reference

tender_174218/683572

Published date

2 October 2018

Closing date

13 July 2018

Contract start date

7 August 2018

Contract end date

8 February 2019

Contract type

Service contract

Procedure type

Open procedure (below threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

As part of the review of evidence on dependence, and the short term discontinuation or longer term withdrawal symptoms associated with prescribed medicines, PHE wishes to commission an external partner to undertake a Rapid Evidence Assessment (REA) which includes a call for papers, and to synthesise the findings into one report that:
a) Describes the harms associated with dependence, and the short term discontinuation and longer term withdrawal symptoms from the following prescribed medicines: opioids for chronic pain (excluding end of life /palliative care/cancer pain), benzodiazepines, Z-drugs, gabapentin and pregabalin (excluding epilepsy treatment), and antidepressants

b) Describes the factors that contribute to the risk of harms associated with dependence and and the short term discontinuation or longer term withdrawal symptoms from the medicines listed in the review.

c) Identifies effective and cost effective approaches to the prevention and treatment of dependence and and the short term discontinuation or longer term withdrawal symptoms from the medicines listed in the review.

d) Summarises evidence about patients' own experiences of the harms caused by prescribed medicines specifically relating to dependence and and the short term discontinuation or longer term withdrawal symptoms from the medicines listed in the review.

e) Identifies and describes existing examples of best practice (e.g. services providing withdrawal support) and evaluates the effectiveness and cost effectiveness of the UK health/social service delivery models that prevent or treat dependence and the short term discontinuation or longer term withdrawal symptoms associated with the medicines listed in the review (as well as health service delivery models in other countries that might inform UK provision).

More information

Attachments

Links

Additional text

Instructions to Bidders:

If not already done so, you will need to register your organisation on our Bravo e-Tendering Portal. This is free of charge and a one-off requirement.
https://phe.bravosolution.co.uk

Once registered please navigate to Project 4641 or ITT 3401.

There is a help desk facility provided by Bravo in case of any difficulty: 0800 069 8630 Option 1.

About the buyer

Contact name

Tim Purchase

Address

Salisbury
Salisbury
SP4 0JG
England

Telephone

01980 612648

Email

tim.purchase@phe.gov.uk